Socialstyrelsens riktlinjer - Svensk Kirurgisk Förening

9. Easton, D. F., L. Steele, et al. (1997). “Cancer risks in two large breast cancer
families linked to BRCA2 on chromosome 13q12-13.” Am J Hum Genet
61(1):120-8.
10. Porter, D. E., B. B. Cohen, et al. (1994). “Breast cancer incidence, penetrance
and survival in probable carriers of BRCA1 gene mutation in families
linked to BRCA1 on chromosome 17q12-21.” Br J Surg 81(10):1512-5.
11. Moller, P., A. Borg, et al. (2002). “Survival in prospectively ascertained familial
breast cancer: analysis of a series stratified by tumour characteristics,
BRCA mutations and oophorectomy.” Int J Cancer 101(6):555-9.
12. Foulkes, W. D., P. O. Chappuis, et al. (2000). “Primary node negative breast
cancer in BRCA1 mutation carriers has a poor outcome.” Ann Oncol 11(3):
307-13.
13. Johannsson, O. T., J. Ranstam, et al. (1998). “Survival of BRCA1 breast and
ovarian cancer patients: a population-based study from southern Sweden.” J
Clin Oncol 16(2):397-404.
14. Einbeigi, Z., A. Bergman, et al. (2001). “A founder mutation of the BRCA1
gene in Western Sweden associated with a high incidence of breast and ovarian
cancer.” Eur J Cancer 37(15):1904-9.
15. Loman, N., O. Johannsson, et al. (2000). “Prognosis and clinical presentation
of BRCA2-associated breast cancer.” Eur J Cancer 36(11):1365-73.
16. Verhoog, L. C., C. T. Brekelmans, et al. (1999). “Survival in hereditary breast
cancer associated with germline mutations of BRCA2.” J Clin Oncol 17(11):
3396-402.
17. Gail, M. H., L. A. Brinton, et al. (1989). “Projecting individualized probabilities
of developing breast cancer for white females who are being examined
annually.” J Natl Cancer Inst 81(24):1879-86.
18. Claus, E. B., N. Risch, et al. (1994). “Autosomal dominant inheritance of earlyonset
breast cancer. Implications for risk prediction.” Cancer 73(3):643-51.
19. Easton, D. F., D. Ford, et al. (1995). “Breast and ovarian cancer incidence in
BRCA1-mutation carriers. Breast Cancer Linkage Consortium.” Am J Hum
Genet 56(1):265-71.
20. Anglian, B. C. S. G. (2000). “Prevalence and penetrance of BRCA1 and BRCA2
mutations in a population-based series of breast cancer cases.“ Br J Cancer
83(10):1301-8.
21. Antoniou, A., P. Pharoah, et al. (2003). “Average risks of breast and ovarian
cancer associated with mutations in BRCA1 or BRCA2 detected in case
series unselected for family history: a combined analysis of 22 studies.” Am
J Hum Genet.
22. Struewing, J. P., P. Hartge, et al. (1997). “The risk of cancer associated with
specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.” N Engl
J Med 336(20):1401-8.
40